Top

Published in:

01-01-2008 | Research Articles

Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer

Authors: Antonio Jimeno, Cristina Grávalos, Pilar Escudero, Isabel Sevilla, M. Eugenia Vega-Villegas, Vicente Alonso, Ignacio Juez, Rocío García-Carbonero, Humberto Bovio, Ramón Colomer, Hernán Cortés-Funes

Published in: Clinical and Translational Oncology | Issue 1/2008

Title: Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer
Authors: Antonio Jimeno
Cristina Grávalos
Pilar Escudero
Isabel Sevilla
M. Eugenia Vega-Villegas
Vicente Alonso
Ignacio Juez
Rocío García-Carbonero
Humberto Bovio
Ramón Colomer
Hernán Cortés-Funes
Publication date: 01-01-2008
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 1/2008
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-008-0153-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2008

Molecular cytogenetics in translational oncology: when chromosomes meet genomics

Littoral cell angioma of the spleen

Prognostic factors in cancer of unknown primary site

Incorporating new therapies in the treatment of paediatric solid tumours

The TGFß pathway as a therapeutic target in cancer

Use of radiation treatment units in breast cancer. Changes in the last 15 years

Keynote webinar | Spotlight on antibody–drug conjugates in cancer